Recent advances of targeted therapy in relapsed/refractory acute myeloid leukemia

Despite advances in the understanding of disease pathobiology, treatment for relapsed or refractory acute myeloid leukemia (R/R AML) remains challenging. The prognosis of R/R AML remains extremely poor despite chemotherapy and bone marrow transplants. Discoveries on recurrent and novel genetic mutat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Jiale, Ge, Zheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292864/
https://www.ncbi.nlm.nih.gov/pubmed/33577442
http://dx.doi.org/10.17305/bjbms.2020.5485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8292864/
https://www.ncbi.nlm.nih.gov/pubmed/33577442
http://dx.doi.org/10.17305/bjbms.2020.5485

Ejemplares similares